Danimer Scientific, Inc. (NYSE:DNMR) – Stock analysts at Jefferies Financial Group boosted their FY2022 earnings per share (EPS) estimates for Danimer Scientific in a research note issued to investors on Wednesday, September 22nd. Jefferies Financial Group analyst L. Alexander now anticipates that the company will post earnings per share of $0.10 for the year, up from their prior estimate of $0.05.
Other equities analysts have also issued research reports about the stock. Cowen began coverage on shares of Danimer Scientific in a research report on Thursday. They set an “outperform” rating and a $21.00 price objective on the stock. Zacks Investment Research upgraded Danimer Scientific from a “sell” rating to a “hold” rating in a report on Thursday.
Danimer Scientific (NYSE:DNMR) last issued its quarterly earnings data on Monday, August 16th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.03). The company had revenue of $14.47 million for the quarter.
In other Danimer Scientific news, CMO Scott Tuten sold 10,000 shares of Danimer Scientific stock in a transaction on Friday, September 17th. The shares were sold at an average price of $16.56, for a total transaction of $165,600.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Several hedge funds and other institutional investors have recently modified their holdings of DNMR. Commonwealth Equity Services LLC raised its holdings in shares of Danimer Scientific by 431.9% in the first quarter. Commonwealth Equity Services LLC now owns 51,558 shares of the company’s stock valued at $1,946,000 after buying an additional 41,865 shares during the last quarter. The PNC Financial Services Group Inc. bought a new position in shares of Danimer Scientific in the first quarter valued at about $42,000. Cambridge Investment Research Advisors Inc. bought a new position in shares of Danimer Scientific in the first quarter valued at about $250,000. BlackRock Inc. bought a new position in shares of Danimer Scientific in the first quarter valued at about $54,947,000. Finally, Diversified Trust Co bought a new position in shares of Danimer Scientific in the first quarter valued at about $2,265,000. 46.71% of the stock is owned by institutional investors.
Danimer Scientific Company Profile
Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petrochemical-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including water bottles, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.
Further Reading: Understanding the different types of bonds
Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.